Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 60
Tesamorelin UK: price and NHS access
Tesamorelin has no MHRA authorisation and no NICE appraisal. No NHS route, no regulated UK price. Why the EU application was withdrawn and what it means.
Tesamorelin in the UK: regulatory status
Tesamorelin has no MHRA marketing authorisation. The 2012 EMA withdrawal left it unauthorised across the UK. What that means for supply, import, and athletes.
Tirzepatide UK: NHS price and private costs
Mounjaro's NHS price is commercial-in-confidence. Private prescriptions run £149-£400/month by dose. Here is how NICE TA924 and TA1026 shape who pays what.
Tirzepatide in the UK: regulatory status
Mounjaro is MHRA-authorised for T2D and weight management. What NICE TA924 and TA1026 decide, what safety signals have appeared, and what changed in 2025-2026.
BPC-157 US import rules: the FDA position
BPC-157 has no FDA approval and no legal basis for personal importation for human use. Here is what the US regulatory framework and border rules actually say.
BPC-157 in the US: price and access
No FDA approval, no compounding pathway, no regulated price. What grey-market costs and the US regulatory picture look like for BPC-157.
TB-500 in the UK: regulatory status
TB-500 holds no UK marketing authorisation. Here is how the Human Medicines Regulations 2012 and the WADA S2 ban apply to the peptide in Britain.
Tesamorelin UK personal import rules
UK law exempts personal imports of medicines from the manufacturer's licence rule. Tesamorelin is unlicensed here, and selling it is a separate offence.
Can you import tirzepatide into the UK?
Tirzepatide sold as Mounjaro is a licensed prescription-only medicine in the UK, which changes the personal-import question completely.
What ipamorelin actually costs in the UK
Ipamorelin has no UK price because it is not a licensed medicine. No NHS cost, no private prescription rate, only grey-market listings and the risk behind them.
MOTS-c and BPC-157: the evidence so far
MOTS-c and BPC-157 are unapproved peptides with mostly animal evidence. Here is what the research shows and what an FDA panel just voted on.
Peptide healing stacks after surgery
Peptide healing blends combine BPC-157, TB-500 and GHK-Cu. Here is what the evidence does and does not support for recovery after surgery.